Gutamin 550
Rifaximin (550mg)

About this product
Broad In-Gut Antibacterial Activity against a wide range of gram-positive, gram-negative, aerobic, and anaerobic gut organisms.

Overview
Gutamin 550 addresses the key limitations of existing hepatic encephalopathy management options such as lactulose monotherapy's unpredictable titration and breakthrough episodes, systemic antibiotics like neomycin with their nephrotoxicity and ototoxicity risks, and escalating lactulose doses that fail to target bacterial ammonia production while risking dehydration. With minimal systemic absorption, it stays concentrated in the gut lumen where ammonia-producing bacteria reside, limiting systemic side effects and drug interactions while offering broad antibacterial activity against the gram-positive, gram-negative, aerobic, and anaerobic organisms implicated in ammonia production.
Indications
Related Products

UrsotOS 300
Ursodeoxycholic Acid (300mg)
Trusted long-term disease-modifying therapy for primary biliary cholangitis and chronic cholestatic liver disease.

EsomatOS 40
Esomeprazole (40mg)
Acid suppression for patients unable to take oral therapy, indicated in erosive GERD and prevention of rebleeding after endoscopic treatment of gastric or duodenal ulcers.
Partner With Schemic Concepts
Engineer better health outcomes with precision-driven pharmaceuticals
Healthcare is moving toward greater digital integration and evidence-based care. Schemic Concepts is built to move with it